Filing Flows › Hyster-Yale (HY) › Q2 2026 › vs Q2 2025
Hyster-Yale (HY) Q2 2026 vs Q2 2025 (year over year)
Hyster-Yale's revenue fell $144M (-15%) from $957M in Q2 2025 to $813M in Q2 2026.
Hyster-Yale, Q2 2026: revenue $813M (-15% year over year), operating margin -2.3%, net loss $31.3M, operating cash flow $16.7M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 0.2% | 1.6% | -1.3 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $813M | $957M | −$144M | -15% |
| Net loss | $31.3M | $13.4M | $17.9M | +134% |
| Costs & expenses | $844M | $970M | −$126M | -13% |
| Operating costs | $831M | $965M | −$134M | -14% |
| Interest & other, net | $4.8M | $4.7M | $100K | +2% |
| Income tax | $8.1M | $200K | $7.9M | 40× |
| Cost of revenue | $685M | $788M | −$103M | -13% |
| SG&A | $144M | $161M | −$16.7M | -10% |
| Other operating costs | $1.7M | $15.7M | −$14.0M | -89% |
| Operating cash sources | $48.0M | $42.3M | $5.7M | +13% |
| Depreciation & amortization | $10.9M | $11.8M | −$900K | -8% |
| Share-based compensation | $1.4M | $2.7M | −$1.3M | -48% |
| Working capital & other | $35.7M | $27.8M | $7.9M | +28% |
| Net loss absorbed | $31.3M | $13.4M | $17.9M | +134% |
| Operating cash flow | $16.7M | $28.9M | −$12.2M | -42% |
| Free cash flow (OCF − capex) | $2.0M | $15.1M | −$13.1M | -87% |
| Capital expenditures | $14.7M | $13.8M | $900K | +7% |
Questions
How much did Hyster-Yale's revenue grow year over year in Q2 2026?
Hyster-Yale's revenue fell $144M (-15%) from $957M in Q2 2025 to $813M in Q2 2026.